Fascin expression in pleomorphic adenoma and mucoepidermoid

Carcinoma by Rahrotaban, Sedigheh et al.
Dental Research Journal
Dental Research Journal  /  May 2014  /  Vol 11  /  Issue 3370
Original Article
Fascin expression in pleomorphic adenoma and mucoepidermoid 
carcinoma
Sedigheh Rahrotaban1, Faezeh Azmoudeh2, Seyedeh Mahboubeh Kiyani3
1Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, 2Department of Oral 
and Maxillofacial Pathology and Dental Caries Research Center, School of Dentistry, Qazvin University of Medical Sciences, Qazvin, 3Dentist, Iran
ABSTRACT
Background: Salivary gland tumors constitute an important part of oral and maxillofacial 
pathology. Pleomorphic adenoma (PA) and mucoepidermoid carcinoma (MEC) are the most 
common benign and malignant salivary gland tumors. Fascin is an actin-bundling protein that 
increases the motility of normal and transformed epithelial cells. The aims of the study were 
to determine the expression of fascin in these tumors and to determine its role in their 
progression.
Materials and Methods: A total of 40 formalin-fixed, paraffin-embedded tissue blocks of PA, and 
20 blocks of MEC were included in this study. Diagnostic confirmation was performed through 
examination of hematoxylin and eosin sections. Both tumors were immunohistochemically analyzed 
for the presence of fascin using Avidin-Biotin complex method and evaluated via light microscope 
by 2 independent observers. Statistical analysis was performed using Kruskal-Wallis and Chi-square 
tests with significant level of P < 0.05.
Results: In both the tumors, the percentage of stained cells was significantly correlated with intensity 
of staining (P = 0.01 in PA and P = 0.00 in MEC). In PA, statistical analysis showed a significant direct 
correlation between percentage of stained cells and recurrence (P = 0.00).
There was no significant correlation between intensity and percentage of staining with 
clinicopathologic factors in MEC. 
Conclusion: Fascin might be a useful marker for recurrence of PAs and patients with high fascin 
expression in primary PA should be followed up periodically to detect potential recurrence as 
soon as possible.
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INTRODUCTION
Human fascin is a highly conserved 55-kDa actin-
bundling protein that is considered to be involved 
in the assembly of actin filament bundles present in 
microspikes as well as in membrane ruffles and stress 
fibers.[1-3]
The expression of fascin is highly specific to tissue 
and cell types. Fascin is plentifully expressed in 
tissues such as brain and spleen and in specific types 
of cells such as neuronal and glial cells, microcapillary 
endothelial cells, and antigen-presenting dendritic 
cells.[4,5]
The expression of fascin in epithelial neoplasms has 
been described only recently. In normal epithelial 
cells, fascin expression is usually absent or very low 
but is often upregulated in several types of human 
neoplasms, such as ovarian, breast, pancreatic, colon, 
lung, and skin tumors.[6,7]
It’s overexpression results in decreased cell-to-cell 
adhesion and increased epithelial cell motility.[8,9]
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Salivary gland tumors include a significant part of 
oral tumors and are the next common neoplasm 
of the mouth after squamous cell carcinoma.[10] 
Pleomorphic adenoma (PA) of the parotid gland is 
the most common salivary gland tumor. Regardless 
of modern microsurgical techniques, recurrence 
rates remain at about 5% after operation. Repeated 
operations increase the risk of facial paralysis and the 
risk of malignant transformation with time.[11] Brieger 
et al. showed that fascin might be a useful marker for 
recurrence of PA.[10]
Mucoepidermoid carcinoma (MEC) is one of the 
most common salivary gland malignancies. MEC is 
regularly seen in the 35 to 65 year-old age group, 
but it is also the commonest salivary malignancy 
in children. MEC is reported to manifest variable 
biologic aggressiveness, basically showing association 
with its histological features.[11,12]
Few studies have targeted fascin expression only 
in one type of salivary gland tumors. Thus, this 
retrospective study was performed to determine the 
expression of fascin in PA and MEC and its possible 
association with the clinic opathologic features of the 
sample. 
MATERIALS AND METHODS
Tissue samples
In this descriptive-analytical study, the achieved 
tissue samples from 40 cases of PA and 20 cases of 
MEC specimens were selected. Diagnosis was based 
on histopathological examination of hematoxylin 
and eosin-stained sections. The patients with PA 
consisted of 17 men and 23 women with mean age 
of 37.52 years and the cases with MEC consisted of 
7 men and 13 women with mean age of 48.45 years, 
who had undergone surgery between 2002 and 2011. 
Metastatic and recurrent tumors and small samples 
were excluded. At the time of this study, we recalled 
the patients, 48 cases of 60 presented for their recall 
appointment and 10 recurrences of 36 PA were found, 
and one of the 12 MEC patients expired because of 
the tumor.
Immunohistochemistry
3 to 4 micron sections from paraffin-embedded 
specimens were mounted on poly-L-lysine-coated 
glass slides. 
After rinsing with 3 changes of xylol for 
deparaffinization, the sections were rehydrated with 
5 changes of alcohol (100%, 100%, 95%, 85%, and 
75%). In order to inactivate endogenous peroxidase, 
sections were incubated for 5 minutes in 3% H2O2, 
and were then rinsed with phosphate-buffered saline 
(PBS). 
Specimens were stained with the monoclonal anti-
fascin (Dako, Denmark) at a dilution of 1:50 by using 
Avidin-Biotin complex method and evaluated via 
light microscope (Olympus BX41TF, Tokyo, Japan) 
by 2 independent observers who were unaware of the 
diagnosis. 
Positive controls consisted of stained endothelial 
cells as internal control and tissue specimen sections 
of Hodgkin lymphoma with notorious antigenic 
reactivity. A negative control was stained by omitting 
the primary antibody. 
Specimen evaluation
Intensity was determined in comparison with 
endothelial cells with high known reactivity as 
internal control. Intensity and percentage of staining 
was scored on the basis of modified semiquantitive 
Bittinger analysis so that scale of 0 to 4 was used 
to score relative intensity with 0 corresponding to 
no detectable immunoreactivity and 1, 2, 3, and 
4 for very low, low, moderate, and high staining, 
respectively. Then, the percentage of positive cells 
was determined and a scale of 1 to 4 was used; so 
that 1 showed staining of ≤5% of cells and 2, 3, 
and 4 showed 5 to 20%, 20 to 50%, >50% staining, 
respectively (10).
Statistical analysis
Statistical analysis was performed using Kruskal-
Wallis and Chi-square tests with significant level of 
P < 0.05.
RESULTS
In this study, we examined fascin expression in PA 
and MEC. In both the tumors, we didn’t have 0 score, 
it means all the tumors expressed fascin in epithelial 
tumoral cells. Figure 1 shows fascin expression in PA 
and MEC.
There was no correlation between PA and MEC 
intensity and percentage of staining, as shown in 
Table 1 (P > 0.05)
In both the tumors, the percentage of stained cells 
was significantly correlated with intensity of staining 
(P = 0.01 in PA and P = 0.00 in MEC).
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In PA, statistical analysis showed a significant direct 
correlation between percentage of stained cells and 
recurrence (P = 0.00) [Table 2]. In addition, there 
was a significant inverse correlation between intensity 
and patients’ age, so that higher intensity was seen in 
younger patients (P = 0.03).
There was no significant correlation between intensity 
and percentage of staining with clinicopathologic 
factors in MEC.
DISCUSSION
The application of immunohistochemical method in 
pathology has been resulted in marked improvement 
in microscopic diagnosis of neoplasms and more exact 
realization of histopathologic features, histogenesis, 
pathogenesis, and prognosis of those lesions.[13] Fascin 
is an immunohistochemical marker, the expression 
of which has been studied in many cancers and 
most of these studies have shown increase of its 
level.[14-21] Fascin expression has been shown to be a 
poor prognostic factor in gastric and esophageal cancer.
[22,23] It is also suggested that fascin can be explored as 
a new therapeutic target for oral and breast cancer.[24,25] 
In the oral cavity, there are some studies about fascin 
expression in squamous cell carcinoma.[22-30]
Salivary gland tumors include a significant part of 
oral tumors and are the next common neoplasm of 
the mouth after squamous cell carcinoma. Some 
prognostic molecular markers such as platelet-
derived growth factor (PDGF), fibroblast growth 
factor (FGF), and Claudin have been related 
to the prognosis of common salivary gland 
tumors.[31,32] However, only few studies is published 
about salivary gland tumors.[10] In this study, 
although there was no significant difference between 
fascin expression in PA and MEC, a significant 
correlation between percent of stained cells and 
PA recurrence was found. This could be because of 
fascin’s role in the formation of cellular dendrite 
and pseudopodia that develop beyond the tumor’s 
capsule and help the recurrence of the tumor.[33-35]
These results are consistent with Brieger et al.’s study 
which reported higher expression of fascin in primary 
PA with recurrence and also in recurred tumors.[10]
In addition, there was an inverse correlation between 
intensity of staining and patient’s age; the younger 
patients had higher fascin expression. As we know, 
PA in younger patients is more susceptible to 
recurrence.
As MEC is a malignant tumor with more invasive 
behavior and because of fascin role in motility and 
migration of cells according to previous studies in 
malignancies,[15,36] we expect to see higher expression 
of fascin in MEC than PA, but this was not shown 
in our results. This could be because of limited 
number of MEC specimens and also impossibility 
of considering histopathologic grade because most 
specimens were removed by incisional biopsy.
CONCLUSION
On the basis of our observations, it is suggested that 
fascin might be a useful marker for recurrence of PA 
and patients with high fascin expression in primary 
PA should be followed up periodically to detect 
potential recurrence as soon as possible.
It is also recommended to analyze fascin expression 
in higher numbers of patients with MEC, considering 
different grades of this tumor.
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Table 1: Intensity and percentage of staining
Tumor Intensity of staining Percentage of stained cells
0 1 2 
(%)
3 
(%)
4 
(%)
0 1 
(%)
2 
(%)
3 
(%)
4 
(%)
PA 0 0 17.5 50 32.5 0 10 12.5 35 42.5
MEC 0 0 30 40 30 0 15 10 20 55
Table 2: Percentage of stained cells with fascin in 
pleomorphic adenoma cell 
Percentage of stained cells <5% 5-20% 20-50% >50%
PA with recurrence 10 0 0 90 P=0
PA without recurrence 11.5 19.2 50 19.2
a b
Figure 1: Fascin expression in (a) pleomorphic adenoma (40×) 
and (b) mucoepidermoid carcinoma (40×)
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